Company Search:
Advanced Search
Sponsored Links
NextCell Pharma AB Company Snapshot
NextCell Pharma AB operates within the Health and allied services sector. In addition to historical fundamental analyses, the complete report available to purchase compares NextCell Pharma AB with three other health care providers in Europe: Celyad Oncology of BELGIUM (2019 sales of 6,000.00 Euros [US$7,117.44 ] of which 100% was Cardiology), Swissmed Centrum Zdrowia SA of POLAND (19.96 million Polish New Zlotys [US$5.18 million] ), and Euroespes SA which is based in SPAIN (2.37 million Euros [US$2.82 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
NextCell Pharma AB
  Stock Performance Chart for NextCell Pharma AB
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 22.30
(Figures in Swedish Kronor)
1 Week -1.8%   13 Weeks -6.3%  
4 Weeks 64.0%   52 Weeks 378.1%  
NextCell Pharma AB Key Data:
  Ticker: NXTCL Country: Sweden
  Exchanges: OTH Major Industry: Health Care Equipment & Services
    Sub Industry: Health & Allied Services
  2019 Sales 1,812,171
(Year Ending Jan 2020).
Employees: N/A
  Currency: Swedish Kronor Market Cap: 453,035,262
  Fiscal Yr Ends: August Shares Outstanding: 20,315,483
  Share Type: Ordinary Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.